LncRNA ILF3-AS1 Promotes the Progression of Colon Adenocarcinoma Cells Through the miR-619-5p/CAMK1D Axis

References

• O’Keefe SJ. Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol. 2016;13(12):691–706. doi:10.1038/nrgastro.2016.165
   PubMed Web of Science ®Google Scholar
• Link KH, Sagban TA, Mörschel M, et al. Colon cancer: survival after curative surgery. Langenbecks Arch Surg. 2005;390(2):83–93. doi:10.1007/s00423-004-0508-5
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–890. doi:10.1016/j.cell.2009.11.007
   PubMed Web of Science ®Google Scholar
• De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013;13(2):97–110. doi:10.1038/nrc3447
   PubMed Web of Science ®Google Scholar
• Bates RC, Pursell BM, Mercurio AM. Epithelial-mesenchymal transition and colorectal cancer: gaining insights into tumor progression using LIM 1863 cells. Cells Tissues Organs. 2007;185(1–3):29–39. doi:10.1159/000101300
   PubMed Web of Science ®Google Scholar
• Silva-Fisher JM, Dang HX, White NM, et al. Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression. Nat Commun. 2020;11(1):2156. doi:10.1038/s41467-020-15547-8
   PubMed Web of Science ®Google Scholar
• Li T, Li Z, Wan H, et al. Recurrence-associated long non-coding RNA LNAPPCC facilitates colon cancer progression via forming a positive feedback loop with PCDH7. Mol Ther Nucleic Acids. 2020;20:545–557. doi:10.1016/j.omtn.2020.03.017
   PubMedGoogle Scholar
• Zhou M, Hu L, Zhang Z, Wu N, Sun J, Su J. Recurrence-associated long non-coding RNA Signature for determining the risk of recurrence in patients with colon cancer. Mol Ther Nucleic Acids. 2018;12:518–529. doi:10.1016/j.omtn.2018.06.007
   PubMedGoogle Scholar
• Han S, Song L, Chen Y, Hou M, Wei X, Fan D. The long non-coding RNA ILF3-AS1 increases the proliferation and invasion of retinoblastoma through the miR-132-3p/SMAD2 axis. Exp Cell Res. 2020;393(2):112087. doi:10.1016/j.yexcr.2020.112087
   PubMed Web of Science ®Google Scholar
• Gao G, Li W, Liu S, et al. The positive feedback loop between ILF3 and lncRNA ILF3-AS1 promotes melanoma proliferation, migration, and invasion. Cancer Manag Res. 2018;10:6791–6802. doi:10.2147/CMAR.S186777
   PubMed Web of Science ®Google Scholar
• Bergamaschi A, Kim YH, Kwei KA, et al. CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer. Mol Oncol. 2008;2(4):327–339. doi:10.1016/j.molonc.2008.09.004
   PubMed Web of Science ®Google Scholar
• Li D, Bao J, Yao J, Li J. lncRNA USP2-AS1 promotes colon cancer progression by modulating Hippo/YAP1 signaling. Am J Transl Res. 2020;12(9):5670–5682.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhan Y, Wang J, Wang J, Guo J, Kong D. lncRNA-SNHG17 promotes colon adenocarcinoma progression and serves as a sponge for miR-375 to regulate CBX3 expression. Am J Transl Res. 2020;12(9):5283–5295.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhan Y, Wang J, Wang J, Guo J, Kong D. Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-κB/YY1 axis. Mol Oncol. 2020;14(12):3211–3233. doi:10.1002/1878-0261.12819
   PubMed Web of Science ®Google Scholar
• Yang X, Lin F, Gao F. Up-regulated long non-coding RNA ILF3-AS1 indicates poor prognosis of nasopharyngeal carcinoma and promoted cell metastasis. Int J Biol Markers. 2020;1724600820955199.
   Web of Science ®Google Scholar
• Ren ZH, Shang GP, Wu K, Hu CY, Ji T. WGCNA co-expression network analysis reveals ILF3-AS1 functions as a CeRNA to regulate PTBP1 expression by sponging miR-29a in gastric cancer. Front Genet. 2020;11:39. doi:10.3389/fgene.2020.00039
   PubMed Web of Science ®Google Scholar
• Hu XH, Dai J, Shang HL, Zhao ZX, Hao YD. SP1-mediated upregulation of lncRNA ILF3-AS1 functions a ceRNA for miR-212 to contribute to osteosarcoma progression via modulation of SOX5. Biochem Biophys Res Commun. 2019;511(3):510–517. doi:10.1016/j.bbrc.2019.02.110
   PubMed Web of Science ®Google Scholar
• Qiu G, Zhang XB, Zhang SQ, et al. Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma. Oncol Lett. 2016;12(6):5036–5042. doi:10.3892/ol.2016.5312
   PubMed Web of Science ®Google Scholar
• Chen G, Gu Y, Han P, Li Z, Zhao JL, Gao MZ. Long noncoding RNA SBF2-AS1 promotes colorectal cancer proliferation and invasion by inhibiting miR-619-5p activity and facilitating HDAC3 expression. J Cell Physiol. 2019;234(10):18688–18696. doi:10.1002/jcp.28509
   PubMed Web of Science ®Google Scholar
• Colak S, Ten Dijke P. Targeting TGF-β signaling in cancer. Trends Cancer. 2017;3(1):56–71. doi:10.1016/j.trecan.2016.11.008
   PubMed Web of Science ®Google Scholar
• Massagué J. TGFbeta in Cancer. Cell. 2008;134(2):215–230. doi:10.1016/j.cell.2008.07.001
   PubMed Web of Science ®Google Scholar
• Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350–1356. doi:10.1038/nm.3967
   PubMed Web of Science ®Google Scholar
• Calon A, Lonardo E, Berenguer-Llergo A, et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat Genet. 2015;47(4):320–329. doi:10.1038/ng.3225
   PubMed Web of Science ®Google Scholar
• Neel J-C, Humbert L, Lebrun -J-J. The dual role of TGFβ in human cancer: from tumor suppression to cancer metastasis. ISRN Mol Biol. 2012;2012:381428. doi:10.5402/2012/381428
   PubMedGoogle Scholar
• Yamada T, Suzuki M, Satoh H, Kihara-Negishi F, Nakano H, Oikawa T. Effects of PU.1-induced mouse calcium-calmodulin-dependent kinase I-like kinase (CKLiK) on apoptosis of murine erythroleukemia cells. Exp Cell Res. 2004;294(1):39–50. doi:10.1016/j.yexcr.2003.10.023
   PubMed Web of Science ®Google Scholar
• Gaines P, Lamoureux J, Marisetty A, Chi J, Berliner N. A cascade of Ca(2+)/calmodulin-dependent protein kinases regulates the differentiation and functional activation of murine neutrophils. Exp Hematol. 2008;36(7):832–844. doi:10.1016/j.exphem.2008.02.009
   PubMed Web of Science ®Google Scholar
• Volpin V, Michels T, Sorrentino A, et al. CAMK1D triggers immune resistance of human tumor cells refractory to anti-PD-L1 treatment. Cancer Immunol Res. 2020;8(9):1163–1179. doi:10.1158/2326-6066.CIR-19-0608
   PubMed Web of Science ®Google Scholar